Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review

Total article views   HTML views PDF downloads Totals
9,223 Dovepress* 7,095+ 499 7,594
PubMed Central* 2,128 401 2,529
Totals 9,223 900 10,123
*Since 12 July 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar